Phibro Animal Health (NASDAQ:PAHC) Stock Rating Upgraded by BNP Paribas Exane

BNP Paribas Exane upgraded shares of Phibro Animal Health (NASDAQ:PAHC - Free Report) from an underperform rating to a neutral rating in a research note released on Monday, MarketBeat.com reports. They currently have $24.00 price target on the stock.

A number of other research analysts have also recently issued reports on PAHC. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday, May 8th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $20.80.

Phibro Animal Health Trading Down 2.0%

Shares of NASDAQ:PAHC traded down $0.49 during trading on Monday, hitting $23.96. 215,002 shares of the company's stock were exchanged, compared to its average volume of 207,130. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $26.55. The firm has a 50-day moving average price of $21.59 and a two-hundred day moving average price of $21.92. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67. The firm has a market cap of $971.10 million, a P/E ratio of 30.72, a PEG ratio of 0.46 and a beta of 0.74.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.63 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.52 by $0.11. The firm had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Equities analysts predict that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Wednesday, June 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.00%. The ex-dividend date is Wednesday, June 4th. Phibro Animal Health's dividend payout ratio (DPR) is presently 61.54%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company's stock valued at $32,500,000 after buying an additional 6,784 shares during the period. Acadian Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company's stock valued at $16,713,000 after buying an additional 4,144 shares during the period. American Century Companies Inc. boosted its holdings in shares of Phibro Animal Health by 18.0% in the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock valued at $13,348,000 after buying an additional 96,787 shares during the period. Nuveen Asset Management LLC boosted its holdings in shares of Phibro Animal Health by 21.4% in the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock valued at $12,348,000 after buying an additional 103,618 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in shares of Phibro Animal Health by 1.9% in the fourth quarter. Renaissance Technologies LLC now owns 557,800 shares of the company's stock valued at $11,714,000 after buying an additional 10,600 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.